Founded in 2014 by Janani Venkatraman, Santanu Datta, and Arindam Ghatak, Biomoneta is pioneering healthcare innovation by tackling one of modern medicine’s most critical challenges: airborne infections.
The startup has developed an advanced air decontamination technology, ZeBox, that is revolutionizing the way we control infections in healthcare and biotech environments.
The Challenge of Airborne Contamination
In environments like hospitals, clinics, and pharmaceutical labs, airborne microbes pose a serious risk, leading to hospital-acquired infections (HAIs), product contamination, and even outbreaks of deadly viruses.
The threat of microbial contamination is amplified in high-risk areas like Intensive Care Units (ICUs), Neonatal ICUs (NICUs), and ambulance environments, where patients often have weakened immune systems, and the spread of infections can have dire consequences.
Similarly, in pharmaceutical and biotech labs, controlling bioburden is crucial to ensuring the integrity of research and production, where contamination can lead to significant financial losses.
Biomoneta’s Solution: ZeBox
At the heart of Biomoneta’s innovative approach is ZeBox, a cutting-edge air decontamination device.
ZeBox is designed to remove airborne microbes in real-time, with its patented technology offering a proven >99.999% reduction of pathogens, including bacteria, viruses, fungi, and spores, within 20 minutes.
What sets it apart is its ability to operate in environments with human presence, providing continuous protection with zero downtime and low lifetime maintenance.
ZeBox’s applications are broad, from ensuring safety in hospital ICUs and ambulances to controlling bioburden in pharmaceutical production environments.
It has been rigorously tested, including a study by the Indian Institute of Science that demonstrated the device’s effectiveness against airborne COVID-19 particles, destroying over 10 million virus particles in just five minutes.
Addressing Critical Needs in Healthcare
Hospitals and healthcare facilities are under constant pressure to reduce the risk of infections, especially in high-risk areas.
In ICUs and NICUs, where patients are most vulnerable, the presence of airborne pathogens can lead to prolonged hospital stays, complications, and even death.
With ZeBox, these environments can be safeguarded against harmful microorganisms, drastically reducing the risk of Hospital Acquired Infections (HAIs).
In ambulances, where patients with compromised immune systems are transported daily, ZeBox ensures that the air remains free from harmful pathogens, protecting both patients and medical staff.
Its use in mobile ICUs and portable healthcare facilities further demonstrates its potential to enhance infection control in remote or resource-poor settings.
Biotech and Pharma: Protecting Products and Research
ZeBox is not just limited to healthcare applications. The pharmaceutical and biotechnology industries face unique challenges when it comes to preventing microbial contamination in controlled environments.
In tissue culture labs, change rooms, and production facilities, ZeBox plays a critical role in ensuring sterile environments, helping to safeguard the integrity of life-saving products and research.
By ensuring ultra-safe environments in these sensitive spaces, ZeBox helps reduce the risk of contamination, which could otherwise lead to production delays, product recalls, or compromised research outcomes.
A Journey of Innovation and Recognition
Biomoneta’s journey has been fueled by a passion for improving human health and well-being.
The company has received recognition from both the Indian and Karnataka governments and has been supported by leading healthcare investors, both from Japan and India. Biomoneta is also a part of the C-CAMP portfolio, reflecting its strong backing in the health-tech ecosystem.
The company has already received several prestigious awards, including grants from the Government of India and Karnataka, and industry recognition from bodies such as the Confederation of Indian Industry (CII) and the Association of Biotechnology Led Enterprises (ABLE).
These accolades have helped solidify Biomoneta’s position as one of India’s most promising healthcare startups.
A Safer, Healthier Future
Biomoneta’s ZeBox is a game-changer in the fight against airborne pathogens. It’s not just a technology but a solution that saves lives, reduces risk, and offers businesses in the healthcare and biotech sectors peace of mind.
With its proven track record, cutting-edge innovation, and real-world application, Biomoneta is leading the charge in creating a safer, germ-free future for hospitals, labs, and public health systems worldwide.
As the world continues to face the challenges of emerging infectious diseases and antibiotic-resistant organisms, Biomoneta’s mission to transform the way we control airborne infections has never been more crucial.
The company’s unwavering commitment to saving lives and preventing the spread of infections has positioned it at the forefront of a new era in infection control.
